[1]骆昱晖,杨菲菲,张 宏.多酸化合物的药学应用进展[J].常州大学学报(自然科学版),2014,(04):23-29.[doi:10.3969/j.issn.2095-0411.2014.04.006 ]
 LUO Yu hui,YANG Feifei,ZHANG Hong.Research Progress of Polyoxometalates in the Application of Pharmacy[J].Journal of Changzhou University(Natural Science Edition),2014,(04):23-29.[doi:10.3969/j.issn.2095-0411.2014.04.006 ]
点击复制

多酸化合物的药学应用进展()
分享到:

常州大学学报(自然科学版)[ISSN:2095-0411/CN:32-1822/N]

卷:
期数:
2014年04期
页码:
23-29
栏目:
生物医学工程
出版日期:
2014-08-31

文章信息/Info

Title:
Research Progress of Polyoxometalates in the Application of Pharmacy
作者:
骆昱晖杨菲菲张 宏
东北师范大学 化学学院,吉林 长春 130024
Author(s):
LUO Yu huiYANG FeifeiZHANG Hong
Department of Chemistry,Northeast Normal University,Changchun 130024,China
关键词:
多金属氧酸盐 药物化学 抗艾滋病 抗肿瘤 抗病毒
Keywords:
polyoxometalate medicinal chemistry anti HIV antitumor antivirus
分类号:
R 914
DOI:
10.3969/j.issn.2095-0411.2014.04.006
文献标志码:
A
摘要:
介绍了多金属氧酸盐化学的发展过程,综述了多酸化合物的药学应用进展,包括其在抗艾滋病(HIV)、抗肿瘤、抗病毒等方面的研究情况。同时,展望了未来多酸药学应用研究的主要领域及亟需解决的关键问题。
Abstract:
This paper briefly introduced the development process of the polyoxometalate chemistry.The application process of polyoxometalates in pharmacy was reviewed,including their pharmacological action against HIV,tumor and virus.The new pharmaceutical applications of polyoxometalates in the future and the key problems to be urgently solved were also discussed.

参考文献/References:

[1]Pope M T.Heteropoly and Isopoly Oxometalates[M].Berlin:Springer-Verlag,1983:1-10.
[2]Berzelius J.The preparation of phosphomolybdate ion [PMo12O40]3-[J].J Pogg Ann,1826,6:369-380.
[3]Keggin J F.The structure and formula of 12-phosphotungstic Acid[J].ProcR Soc,1934,144A:75-100.
[4]Anderson J S.Constitution of the poly-acids[J].Nature,1937,140:850-850.
[5]Dawson B.The structure of the 9(18)-heteropoly anion in potassium 9(18)-tungstophosphate,K6(P2W18O62)·14H2O[J].Acta Crystallogr,1953,6:113-126.
[6]Waugh J C T,Schoemaker D P.On the structure of the heteropoly anion in ammonium 9-molybdomanganate,(NH4)6MnMo9O32·H2O[J].Acta Crystallogr,1954,7:438-441.
[7]Tsay Y H,Silverton J V.The Crystal structure of magnesium paratungstate,Mg5H2W12O42·38H2O[J].Z Krist,1973,137:256-279.
[8]Lindqvist I.A crystal structure investigation of the paramolybdate ion[J].Ark Kemi,1950,2:325-341.
[9]Matsumoto K Y,Kato M,Sasaki Y.DFT-based theoretical calculations,relevantto the gas[J].Bull Chem Soc Jpn,1976,49:106-110.
[10]王恩波,李阳光,鹿颖,等.多酸化学概论[M].长春:东北师范大学出版社,2009.
[11]王恩波,胡长文,许林.多酸化学导论[M].北京:北京工业大学出版社,1998.
[12]Raynaud M,Chermann J C,Plata F,et al.Viral inhibitors of murine leukemia-sarcoma group Tungstosilicate[J].C R Acad Sci,Ser D,1971,272:347-348.
[13]Rhule J T,Hill C,Judd D A.Polyoxometalates in Medicine[J].Chem Rev,1998,98:327-357.
[14]Fischer J,Richard L,Weiss R.The structure of the heteropolytungstate:An inorganic cryptato[J].J Am Chem Soc,1976,98(10):3050-3052.
[15]Jasmin C,Chermann J C,Herve G,et a1.In vivo inhibition of murine leukemiaand sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate[J].J Natl Cancer Inst,1974,53:469-474.
[16]Dormont D,Spire B,Barre-Sinoussi F,et a1.Inhibition of RNA-dependent DNApolymerases of AIDS and SAIDS retroviruses by HPA-23(ammonium-21-tungsto-9-antimoniate)[J].Ann Inst Pasteure/Virol,1985,136E(1):75-83.
[17]Tomita K,Yamase T,Shishido K.Medical chemistry of polyoxometalates.Part 2.Enzymatic study on binding of heptamolybdate to DNA[J].Inorg Chim Acta,1989,157(2):167-169.
[18]Deborah A J,James H N,Neysa N,et al.Polyoxometalate HIV-1 protease inhibitors.A new mode of protease inhibition[J].J Am Chem Soc,2001,123:886-897.
[19]Liu S X,Li Y G,Han Z B,et al.Synthesis,anti-HIV-1 activity and toxicity of new rare earth-containing heteropoly blues[J].Chem J Chin Univ,2002,23(5):777-782.
[20]Liu S X,Wang E B,Zhai H J,et al.Synthesis,anti-HIV-1 activity study of Keggin type heteropoly blues containing glycine[J].Acta Chimica Sinica,2004,62(2):170-175.
[21]Mathé G,Schwarzenberg L,Jasmin C,et al.Two epipodophyllotoxin derivatives,VM 26 and VP 16213,in the treatment of leukemias, hematosarcomas,and lymphomas[J].Cancer,1974,34:985-992.
[22]Ogata1 A,Yanagie H,Ishikawa1,et al.Antitumour effect of polyoxomolybdates:induction of apoptotic cell death and autophagy in in vitro and in vivo models[J].Br J Cancer,2008,98:399-409.
[23]刘术侠,王恩波,刘彦勇,等.13-镍(锰)钒杂多酸稀土盐的合成以及其镤盐抗肿瘤活性的研究[J].化学学报,1996,54:673-678.
[24]刘术侠,刘彦勇,刘杰,等.钼系杂多、同多配合物抗肿瘤活性(Ⅱ)[J].应用化学,1996,13:104-106.
[25]Yanagie H,Ogata A,Mitsui S,et al.Anticancer activity of polyoxomolybdate[J].Biomed Pharmacother,2006,60:349-352.
[26]Mitsui S,Ogata A,Yanagie H,et al.Antitumor activity of polyoxomolybdate,[NH3Pri]6[Mo7O24]·3H2O,against human gastric cancer model[J].Biomed Pharmacother,2006,60:353-358.
[27]山濑利博.金属酸化物クラスタ[J].イオンの生理活性,1990,41(10):848.
[28]Yamase T.Antitumoral and antiviral polyoxometalates(inorganic discrete polymers of metal oxide)[M].BocaRaton:CRC Press,1996:365-373.
[29]Fukuda N,Yamase T,Tajima Y.Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and beta-lactamase against methicillin-resistant Staphylococcus aureus[J].Biol Pharm Bull,1999,22(5):463-470.
[30]刘景福,陈亚光,马建方,等.穴状稀土杂多化合物的生物活性研究[J].中国稀土学报,2000,18(3):282-285.
[31]Zhang H,Duan L Y,Lan Y,et al.Synthesis,crystal structure,and photochromismof novel two-dimensional supramolecular networks based on keggin-type polyoxoanion and lanthanide coordination cations[J].Inorg Chem,2003,42:8053-8058.
[32]Zhang H,Lan Y,Duan L Y,et al.Synthesis,properties and crystal structure of a new 12-molybdogermanic salt of lanthanum coordinated to N-methyl-2-pyrrolidone[J].J Coord Chem,2003,56(2):85-94.
[33]李娟,李静,齐燕飞,等.12-钨硼酸5-氟尿嘧啶盐的合成及抗癌活性研究[J].高等学校化学学报,2004,6:1010-1012.
[34]付平平.多酸药物及多酸纳米粒子的生物学效应研究[D].长春:东北师范大学,2005.
[35]Prudent R,Moucadel V,Laudet B,et al.Identification of polyoxometalates asnanomolar noncompetitive inhibitors of protein kinase CK2[J].Chem Biol,2008,15:683-692.
[36]Compain J D,Mialane P,Francis S,et al.Tetra-to dodecanuclear oxomolybdatecomplexes with functionalized bisphosphonate ligands:activity in killing tumorcells[J].Chem Eur J,2010,16:13741-13748.
[37]Moll H E,Zhu W,Oldfield E,et al.Polyoxometalates functionalized by bisphosphonate ligands:synthesis,structural,magnetic and spectroscopic characterizations and activity on tumor cell lines[J].Inorg Chem,2012,51:7921-7931.
[38]Wang L,Zhou B B,Yu K,et al.Novel antitumor agent,trilacunary Keggin-typetungstobismuthate,inhibits proliferation and induces apoptosis in human gastriccancer SGC-7901 cells[J].Inorg Chem,2013,52:5119-5127.
[39]Zhang Y,Shen J Q,Zheng L H,et al.Four polyoxonibate-based inorganic-organic hybrids assembly from bicapped heteropolyoxonibate with effective antitumor activity[J].Cryst Growth Des,2014,14:110-116.
[40]Liu J,Mei W J,Li A X,et al.Inhibition of influenza virus infections in MDCK cells by rare earth borotungstates heteropoly blues with mixed valence[J].Chem J Chin Univ,2004,25(1):1-6.
[41]Liu S X,Wang C L,Yu M,et al.Synthesis and anti-influenza virus activity of polyoxometalates containing amantadine[J].Acta Chim Sinica,2005,63:1069-1074.
[42]Hu D H,Shao C,Guan W,et al.Studies on the interactions of Ti-containing polyoxometalates(POMs)with SARS-CoV 3CLpro by molecular modeling[J].J Inorg Biochem,2007,101(1):89-94.
[43]Li M,Xu C,Wu L,et al.Self-assembled peptide-polyoxometalate hybridnanospheres:two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease[J].Small,2013,9(20):3455-3461.
[44]Geng J,Li M,Ren J S,et al.Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease[J].Angew Chem Int Ed,2011,50(18):4184-4188.
[45]Gao N,Sun H J,Dong K,et al.Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer's disease[J].Nat Commun,2014,5:3422.
[46]Hu J K,Yu X Y,Luo Y H,et al.Hydrothermal syntheses and crystal structuresof two novel inorganic-organic hybrid compounds based on saturated α-Keggin phosphomolybdate clusters[J].Inorg Chem Commun,2013,32:37-41.
[47]Liu J,Pan G H,Mei W J,et al.Synthesis,crystal structure and bioactivity ofheteropolyoxotungstates substituted by niobium[J].Chin J Appl Chem,2001,18(3):220-224.

备注/Memo

备注/Memo:
基金项目:科技部863项目(2007AA03Z218); 国家自然科学基金项目(21271038,21071027)。 作者简介:骆昱晖(1988-),男,江苏连云港人,博士生。通讯联系人:张宏(1966-),Email:zhangh@neuu.edu.cn
更新日期/Last Update: 2014-12-20